首页> 外文OA文献 >The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents

【2h】

The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents

机译：II组和基于III基于钆的造影剂的肾肾上纤维化的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andreu F. Costa;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent A Systematic Review and Meta-analysis [J] . Woolen Sean A., Shankar Prasad R., Gagnier Joel J., JAMA internal medicine . 2020,第2期

机译：患有第4阶段或5阶段慢性肾病患者肾上全身纤维化的风险接受II组钆的造影剂进行系统审查和荟萃分析
2. Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents [J] . Smorodinsky Emmanuil, Ansdell David S., Foster Zeke W., Journal of magnetic resonance imaging: JMRI . 2015,第5期

机译：暴露于Ga基造影剂的慢性肝病患者中肾原性系统纤维化的风险低
3. Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents? [J] . Penfield JG, Reilly RF Seminars in dialysis . 2008,第2期

机译：肾源性系统性纤维化的风险：lin基造影剂之间有区别吗？
4. Evaluation of Arsenazo III as a Contrast Agent for Photoacoustic Detection of Micromolar Calcium Transients [C] . Erika J. Cooley, Pieter Kruizinga, Darren W. Branch, Reporters, markers, dyes, nanoparticles, and molecular probes for biomedical applications II . 2010

机译：评价Arsenazo III作为对比剂用于光声检测微摩尔钙瞬变
5. Co(II), Fe(II), and Ni(II) Complexes for paraCEST Applications and a New Class of Fe(III) Macrocyclic Complexes as T1 MRI Contrast Agents [D] . Snyder, Eric M. 2020

机译：CO（II），Fe（II）和Ni（II）络合物用于Parast应用和新类Fe（III）宏环复合物作为T1 MRI造影剂
6. Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents [O] . Emmanuil Smorodinsky, David S. Ansdell, Zeke W. Foster, -1

机译：暴露于Ga基造影剂的慢性肝病患者中肾源性系统纤维化的风险低
7. Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis [O] . J. Heverhagen, G. Krombach, E. Gizewski 2014

机译：基于细胞外钆的MRI造影剂的应用及肾上全身纤维化的风险

The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents

著录项

引文网络

相似文献

相关主题

期刊订阅